CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
patients assuming nutraceutical containing HAdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03421054
NCT03421054N/ACompleted
CompareCT.gov

Pilot, Open Non-controled Trial to Assess the Feasibility of Implementing Objective Parameters as Primary Endpoints in a Clinical Trial With Patients Affected by Knee Osteoarthritis

River Pharma S.r.l.·interventional·Posted Feb 5, 2018·Updated Oct 1, 2019

In Brief

A clinical study evaluating patients assuming nutraceutical containing HA for Knee Osteoarthritis. Completed, enrolled 8 participants across 1 site.

Detailed Summary

Pilot, open non-controlled trial to assess the feasibility of implementing objective parameters as primary endpoints in a clinical trial with patients affected by knee osteoarthritis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesRomania
CollaboratorsOpera CRO, a TIGERMED Group Company

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 5, 2018
Enrollment StartMar 19, 2018
Primary CompletionApr 15, 2018
Study CompletionMay 14, 2018
TodayJul 2, 2026
Enrollment to primary: 26 daysPosted 8.4 years ago

Interventions

patients assuming nutraceutical containing HAdietary

pain reduction of the affected knee in the patients assuming nutraceutical containing HA